Ambu A/S
General ticker "AMBFF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $4.6B (TTM average)
Ambu A/S does not follow the US Stock Market performance with the rate: -36.1%.
Estimated limits based on current volatility of 0.2%: low 12.72$, high 12.78$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-12-05, amount 0.06$ (Y0.47%)
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [17.79$, 28.61$]
- 2025-09-30 to 2026-09-30 estimated range: [19.35$, 30.87$]
Financial Metrics affecting the AMBFF estimates:
- Positive: with PPE of 158.1 at the end of fiscal year the price was neutral
- Positive: 7.86 < Operating profit margin, % of 11.96
- Negative: negative Industry operating cash flow (median)
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.18
- Positive: Shareholder equity ratio, % of 78.19 > 63.39
- Negative: negative Industry operating income (median)
- Positive: Interest expense per share per price, % of 0.08 <= 0.79
- Positive: 0.33 < Operating cash flow per share per price, % of 2.29
Short-term AMBFF quotes
Long-term AMBFF plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 |
|---|---|---|
| Operating Revenue | DKK4,775.00MM | DKK5,391.00MM |
| Operating Expenses | DKK4,473.00MM | DKK4,746.00MM |
| Operating Income | DKK302.00MM | DKK645.00MM |
| Non-Operating Income | DKK-92.00MM | DKK-345.00MM |
| Interest Expense | DKK86.00MM | DKK27.00MM |
| R&D Expense | DKK295.00MM | DKK325.00MM |
| Income(Loss) | DKK210.00MM | DKK300.00MM |
| Taxes | DKK42.00MM | DKK65.00MM |
| Profit(Loss)* | DKK168.00MM | DKK235.00MM |
| Stockholders Equity | DKK5,393.00MM | DKK5,594.00MM |
| Inventory | DKK907.00MM | DKK1,078.00MM |
| Assets | DKK6,859.00MM | DKK7,154.00MM |
| Operating Cash Flow | DKK518.00MM | DKK813.00MM |
| Capital expenditure | DKK326.00MM | DKK289.00MM |
| Investing Cash Flow | DKK-326.00MM | DKK-289.00MM |
| Financing Cash Flow | DKK-222.00MM | DKK-65.00MM |
| Earnings Per Share** | DKK0.64 | DKK0.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.